قارن الطرق

	AGHDA: تقييم قصور هرمون النمو لدى البالغين	مقياس جودة الحياة في القصور الكظري AddiQoL
المجال	علم الغدد الصماء	علم الغدد الصماء
العائلة	Process / pipeline	Process / pipeline
سنة النشأة	2000	2012
صاحب الطريقة	Anthony Hunt, Garry Werther, Peter Wrightson	Adriana Evers, Jeanieke Tiemensma
النوع	Patient self-report questionnaire	Patient self-report questionnaire
المصدر التأسيسي	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.	Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508.
الأسماء البديلة	AGHDA-25	Addison Quality of Life, AI-QoL
ذات صلة	3	3
الملخص	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.	AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations.